338 related articles for article (PubMed ID: 27387538)
21. Inhibition of human cytochrome P450 enzymes by licochalcone A, a naturally occurring constituent of licorice.
He W; Wu JJ; Ning J; Hou J; Xin H; He YQ; Ge GB; Xu W
Toxicol In Vitro; 2015 Oct; 29(7):1569-76. PubMed ID: 26100226
[TBL] [Abstract][Full Text] [Related]
22. LKY-047: First Selective Inhibitor of Cytochrome P450 2J2.
Phuc NM; Wu Z; O Y; Lee JH; Oh S; Song GY; Liu KH
Drug Metab Dispos; 2017 Jul; 45(7):765-769. PubMed ID: 28461575
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of memantine on human cytochrome P450 activities: prediction of in vivo drug interactions.
Micuda S; Mundlova L; Anzenbacherova E; Anzenbacher P; Chladek J; Fuksa L; Martinkova J
Eur J Clin Pharmacol; 2004 Oct; 60(8):583-9. PubMed ID: 15378224
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
Kim JH; Kwon SS; Jeong HU; Lee HS
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
[TBL] [Abstract][Full Text] [Related]
25.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
26. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
27. Enantiospecific effects of chiral drugs on cytochrome P450 inhibition in vitro.
Krasulova K; Siller M; Holas O; Dvorak Z; Anzenbacher P
Xenobiotica; 2016; 46(4):315-24. PubMed ID: 26338061
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of cytochrome P450 by ethambutol in human liver microsomes.
Lee SY; Jang H; Lee JY; Kwon KI; Oh SJ; Kim SK
Toxicol Lett; 2014 Aug; 229(1):33-40. PubMed ID: 24910189
[TBL] [Abstract][Full Text] [Related]
29. Selective inhibition of cytochrome P450 2D6 by Sarpogrelate and its active metabolite, M-1, in human liver microsomes.
Cho DY; Bae SH; Lee JK; Kim YW; Kim BT; Bae SK
Drug Metab Dispos; 2014 Jan; 42(1):33-9. PubMed ID: 24167220
[TBL] [Abstract][Full Text] [Related]
30. Enantiomeric metabolic interactions and stereoselective human methadone metabolism.
Totah RA; Allen KE; Sheffels P; Whittington D; Kharasch ED
J Pharmacol Exp Ther; 2007 Apr; 321(1):389-99. PubMed ID: 17259447
[TBL] [Abstract][Full Text] [Related]
31. Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes.
Raunio H; Juvonen RO; Poso A; Lahtela-Kakkonen M; Rahnasto-Rilla M
Drug Metab Lett; 2016; 10(1):56-64. PubMed ID: 26648056
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits.
Saxena A; Valicherla GR; Joshi P; Saxena R; Cheruvu SH; Bhunia SS; Jain GK; Siddiqui HH; Saxena AK; Gayen JR
Xenobiotica; 2015; 45(11):1016-23. PubMed ID: 26084373
[TBL] [Abstract][Full Text] [Related]
33. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
34. Effect of tubeimoside I on the activity of cytochrome P450 enzymes in human liver microsomes.
Wang R; Zheng K; Liu Y; Ji S; Tang Y; Wang J; Jiang R
Xenobiotica; 2024 Feb; 54(2):57-63. PubMed ID: 38166553
[TBL] [Abstract][Full Text] [Related]
35.
Zhang C; Li Y; Yin C; Zheng J; Liu G
Pharm Biol; 2021 Dec; 59(1):935-940. PubMed ID: 35294326
[TBL] [Abstract][Full Text] [Related]
36. Role of CYP2B6 in stereoselective human methadone metabolism.
Totah RA; Sheffels P; Roberts T; Whittington D; Thummel K; Kharasch ED
Anesthesiology; 2008 Mar; 108(3):363-74. PubMed ID: 18292673
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of (-)-cis- and (-)-trans-rose oxide by cytochrome P450 enzymes in human liver microsomes.
Nakahashi H; Yamamura Y; Usami A; Rangsunvigit P; Malakul P; Miyazawa M
Biopharm Drug Dispos; 2015 Dec; 36(9):565-74. PubMed ID: 26126958
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes.
Lang J; Li W; Zhao J; Wang K; Chen D
Xenobiotica; 2017 Oct; 47(10):849-855. PubMed ID: 27819189
[TBL] [Abstract][Full Text] [Related]
40.
Xu S; Zhang F; Chen D; Su K; Zhang L; Jiang R
Pharm Biol; 2020 Dec; 58(1):308-313. PubMed ID: 32285742
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
